Literature DB >> 6727875

Control of adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites.

C Montell, E F Fisher, M H Caruthers, A J Berk.   

Abstract

The primary transcript from adenovirus 2 early region 1B (E1B) is processed by differential RNA splicing into two overlapping mRNAs, 13S and 22S. The 22S mRNA is the major E1B mRNA during the early phase of infection, whereas the 13S mRNA predominates during the late phase. In previous work, it has been shown that this shift in proportions of the E1B mRNAs is influenced by increased cytoplasmic stability of the 13S mRNA at late times in infection. Two observations presented here demonstrate that the increase in proportion of the 13S mRNA at late times is also regulated by a change in the specificity of RNA splicing. First, the relative concentrations of the 13S to 22S nuclear RNAs were not constant throughout infection but increased at late times. Secondly, studies with the mutant, adenovirus 2 pm2250 , provided evidence that there was an increased propensity to utilize a 5' splice in the region of the 13S 5' splice site at late times in infection. Adenovirus 2 pm2250 has a G----C transversion in the first base of E1B 13S mRNA intron preventing splicing of the 13S mRNA but not of the 22S mRNA. During the early phase of a pm2250 infection, the E1B primary transcripts were processed into the 22S mRNA only. However, during the late phase, when the 13S mRNA normally predominates, E1B primary transcripts were also processed by RNA splicing at two formerly unused or cryptic 5' splice sites. Both cryptic splice sites were located much closer to the disrupted 13S 5' splice site than to the 22S 5' splice site. Thus, the temporal increase in proportion of the 13S mRNA to the 22S mRNA is regulated by two processes, an increase in cytoplasmic stability of the 13S mRNA and an increased propensity to utilize the 13S 5' splice site during the late phase of infection. Adenovirus 2 pm2250 was not defective for productive infection of HeLa cells or for transformation of rat cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727875      PMCID: PMC368849          DOI: 10.1128/mcb.4.5.966-972.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes.

Authors:  R Maki; W Roeder; A Traunecker; C Sidman; M Wabl; W Raschke; S Tonegawa
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

2.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

3.  Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

4.  The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets.

Authors:  J L Bos; L J Polder; R Bernards; P I Schrier; P J van den Elsen; A J van der Eb; H van Ormondt
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

5.  Control of messenger RNA concentration by differential cytoplasmic half-life. Adenovirus messenger RNAs from transcription units 1A and 1B.

Authors:  M C Wilson; J E Darnell
Journal:  J Mol Biol       Date:  1981-05-25       Impact factor: 5.469

6.  Controls of RNA splicing and termination in the major late adenovirus transcription unit.

Authors:  G Akusjärvi; H Persson
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing.

Authors:  J R Nevins; M C Wilson
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

8.  Predicted structure of two adenovirus tumor antigens.

Authors:  M Perricaudet; J M Le Moullec; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Adenovirus terminal protein protects single stranded DNA from digestion by a cellular exonuclease.

Authors:  M Dunsworth-Browne; R E Schell; A J Berk
Journal:  Nucleic Acids Res       Date:  1980-02-11       Impact factor: 16.971

10.  Construction and characterization of new coliphage M13 cloning vectors.

Authors:  J C Hines; D S Ray
Journal:  Gene       Date:  1980-11       Impact factor: 3.688

View more
  22 in total

1.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  E1A and E1B proteins inhibit inflammation induced by adenovirus.

Authors:  Jerome Schaack; Michael L Bennett; Jeff D Colbert; Andres Vazquez Torres; Gerald H Clayton; David Ornelles; John Moorhead
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

3.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

4.  cis-dominant defect in activation of adenovirus type 5 E1b early RNA synthesis.

Authors:  C L Parks; D J Spector
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Sequences upstream of AAUAAA influence poly(A) site selection in a complex transcription unit.

Authors:  J D DeZazzo; M J Imperiale
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Regulation of poly(A) site selection in adenovirus.

Authors:  E Falck-Pedersen; J Logan
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Identification of adenovirus type 2 early region 1B proteins that share the same amino terminus as do the 495R and 155R proteins.

Authors:  J B Lewis; C W Anderson
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

8.  Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen.

Authors:  E White; B Faha; B Stillman
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

9.  Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

10.  Promoter of the adenovirus polypeptide IX gene: similarity to E1B and inactivation by substitution of the simian virus 40 TATA element.

Authors:  L E Babiss; L D Vales
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.